Clinical trials
Multiple Sclerosis (MS) - Relapsing-remitting clinical trials
Below are recruiting multiple sclerosis (ms) - relapsing-remitting clinical trials, each written for real people, not researchers. We’re tracking 233 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07085507RecruitingPhase 1/Phase 2
Testing a new drug for multiple sclerosis in healthy people and MS patients
This trial tests an experimental oral drug called VT7208 in both healthy volunteers and people with multiple sclerosis (MS). The goal is to see if it is safe and how the body processes it, which could lead to a new treatment option for MS.
Adelaide, South AustraliaAges 18–65 - NCT06777134Recruiting
Pelvic floor issues and leg strength in MS patients
This study looks at how pelvic floor problems relate to leg strength and function in people with multiple sclerosis. It may help understand how to better treat these issues.
Istanbul, IstanbulAges 18–65 - NCT05123443Recruiting
Study tracks iron changes in MS brain spots over time
This study looks at how “iron rims” in brain MRI scans change over time in people with multiple sclerosis (MS). It may help researchers understand MS activity better and how iron changes relate to disease progression.
NottinghamAges 16 years+ - NCT06865274Recruiting
A look at gene changes in MS, NMOSD, and MOGAD
This study looks at a specific gene change in people with MS, NMOSD, or MOGAD to see how common it is. By joining, you help researchers learn more about these conditions and possible future treatments.
Roma, RomaAges 18 years+ - NCT07086950Recruiting
Brain training game for thinking skills in multiple sclerosis
This study tests a fun brain-training game designed to improve thinking and memory in people with multiple sclerosis. It may help with everyday mental tasks like concentrating and processing information.
Lausanne, Canton of VaudAges 18 years+ - NCT06890923RecruitingPhase 2
Nasal foralumab for non-active secondary progressive MS
This trial tests a nasal spray medication, foralumab, to see if it can help people with non-active secondary progressive multiple sclerosis. It is only for people who completed a previous related study (TILS-021).
Boston, MassachusettsAges 18–75 - NCT02994121Recruiting
Study of multiple sclerosis in the Three Rivers region
This study follows people with multiple sclerosis (MS) and some healthy people in the local area to better understand MS and related nerve conditions. It may help researchers learn which symptoms and scan changes show up over time.
Pittsburgh, PennsylvaniaAges 7 years+ - NCT06955832Recruiting
Early MS Brain Lesion Detection Using Advanced MRI
This study tests a special type of MRI called Phase Sensitive Inversion Recovery to find brain lesions (areas of damage) in people with multiple sclerosis. The goal is to catch these lesions earlier to help guide treatment.
Banhā, Qalyubia GovernorateAges 15–65 - NCT07710105Recruiting
Ocrevus for MS: A Real-World Study
This study will follow people with multiple sclerosis (MS) who are starting or restarting a treatment called Ocrevus (ocrelizumab). The goal is to understand how well it works in real life over 12 months. Participants will receive Ocrevus as part of their usual care and complete surveys about their experience.
Chicago, IllinoisAges 18 years+ - NCT07582653Enrolling by invitation
Testing a digital health tool for stable multiple sclerosis
This study tests a new digital tool designed to help monitor and manage multiple sclerosis (MS). You'll use the tool as part of regular check-ins, and researchers will see if it helps track your condition better over time.
Exeter, DevonAges 18–80 - NCT06072703Recruiting
Brain stimulation for bladder control in MS
This study tests whether a type of brain stimulation can improve bladder control in women with multiple sclerosis. If you have bladder symptoms like urgency or frequent urination, this trial may help find new ways to manage them.
Houston, TexasAges 18 years+ - NCT07207148Recruiting
Ocrelizumab and weight-loss drugs for MS
This study looks at combining ocrelizumab (an MS treatment) with GLP-1 agonists (like Ozempic, used for weight management) in people with MS. It aims to see if the combination is safe and beneficial.
Chicago, IllinoisAges 18–70 - NCT06795230Recruiting
Arm exercise with blood flow cuffs for MS
This study tests a type of arm exercise that uses a blood pressure cuff to limit blood flow, aiming to improve arm function in people with multiple sclerosis. It may help if you have some arm weakness but no recent relapses or blood clotting issues.
Leganés, MadridAges 18 years+ - NCT05849467RecruitingPhase 1
Testing how the brain absorbs anti–CD8 therapy in nervous system disease
This Phase 1 study tests a small drug (called an anti–CD8+ T cell minibody) to see how much reaches the brain. It may help researchers understand how to deliver similar treatments for multiple sclerosis, progressive multifocal leukoencephalopathy (PML), or other brain inflammation when the brain’s protective barrier is “open.”
Bethesda, MarylandAges 18–120 - NCT06805318Recruiting
Job support program for people with MS
This study tests a vocational rehabilitation program designed to help people with multiple sclerosis (MS) keep their jobs. If you have MS and are currently working, this program may help you stay employed.
Rome, LazioAges 18 years+ - NCT07580820Recruiting
Walking Adaptability in Early-Stage Multiple Sclerosis
This study looks at how people with mild multiple sclerosis (MS) adapt their walking and balance. Researchers will test your walking ability and how your body adjusts to different movements, which could help improve care for people with MS.
DiepenbeekAges 18–65 - NCT07159789Recruiting
Brain stimulation to improve leg weakness in MS
This study tests whether a noninvasive brain stimulation technique (rTMS) can help people with multiple sclerosis who have leg stiffness and weakness. You will receive daily sessions over two weeks to see if it improves walking and quality of life.
Gatineau, QuebecAges 18–70 - NCT07167680Recruiting
Fall prevention for wheelchair users with MS or spinal cord injury
This trial tests a program to help prevent falls for people with multiple sclerosis or spinal cord injury who use a wheelchair or scooter. You will learn physical skills with a care partner to stay safe.
Urbana, IllinoisAges 18 years+ - NCT02649985RecruitingPhase 1/Phase 2
PET brain scan study for several brain and mood conditions
This early-phase study uses PET and MRI brain scans to better understand brain changes in multiple sclerosis, Alzheimer’s disease, and other neurological or mood conditions. The goal is to test whether these scans can show disease-related differences and guide future treatments.
Boston, MassachusettsAges 18–85 - NCT06280742Recruiting
Brain inflammation in multiple sclerosis: a PET-MRI imaging study
This study uses a special PET-MRI scan to look at brain inflammation in people with relapsing-remitting multiple sclerosis (RRMS). It may help researchers understand how inflammation changes when starting a stronger MS treatment.
LyonAges 18 years+ - NCT07236684Recruiting
MS Bladder Control: Study of Muscle Activity
This study looks at how well the pelvic floor muscles work in people with MS who have bladder control problems. It may help find better ways to manage urinary incontinence.
IstanbulAges 30–50 - NCT07087106RecruitingPhase 4
Glucose use in the brain of people with MS
This study uses a special PET scan to see how the brain uses sugar (glucose) in people with multiple sclerosis (MS) compared to healthy volunteers. It may help researchers understand energy changes in the brain related to MS.
Boston, MassachusettsAges 18–70 - NCT05269628RecruitingPhase 2
Cannabidiol for multiple sclerosis sleep and pain patterns
This study looks at whether cannabidiol (CBD, a cannabis-related medicine) can improve symptoms in people with multiple sclerosis (MS), especially how sleep and pain type affect outcomes. It’s mainly for people with MS and ongoing moderate-to-severe pain, while carefully checking safety and medication interactions.
Ann Arbor, MichiganAges 18–65 - NCT07753928Enrolling by invitation
Tracking brain changes in multiple sclerosis
This study looks at how certain brain changes relate to disability in people with multiple sclerosis (MS). It aims to see if measuring brain volume loss can help predict disease progression, which might help tailor treatments.
DresdenAges 18–55
Hear when a new Multiple Sclerosis (MS) - Relapsing-remitting trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for multiple sclerosis (ms) - relapsing-remitting?
- Yes. Clin2 currently lists 233 recruiting multiple sclerosis (ms) - relapsing-remitting studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a multiple sclerosis (ms) - relapsing-remitting trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a multiple sclerosis (ms) - relapsing-remitting trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.